Cronos (CRON) EBT Margin Growth (3y) (2021 - 2026)
Cronos (CRON) EBT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 406.38 Mn | 28.45 Mn | 7,324.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,324.00 |
| Mar 31, 2026 | 31,595.00 |
| Dec 31, 2025 | -13,259.00 |
| Sep 30, 2025 | 20,714.00 |
| Jun 30, 2025 | -29,545.00 |
| Mar 31, 2025 | 20,442.00 |
| Dec 31, 2024 | -359,789.00 |
| Sep 30, 2024 | -181,351.00 |
| Jun 30, 2024 | 111,622.00 |
| Mar 31, 2024 | 126,942.00 |
| Dec 31, 2023 | 71,233.00 |
| Sep 30, 2023 | -62,711.00 |
| Jun 30, 2023 | 106,713.00 |
| Mar 31, 2023 | -108,577.00 |
| Dec 31, 2022 | -74,104.00 |
| Sep 30, 2022 | -12.50 Mn |
| Jun 30, 2022 | -249,478.00 |
| Mar 31, 2022 | -1.06 Mn |
| Dec 31, 2021 | 204,317.00 |